Literature DB >> 9454352

[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].

O Kölbl1, M Flentje, J Eulert, T Barthel, D Knelles, U Kraus.   

Abstract

PURPOSE: Two prospective trials were undertaken to assess the comparative efficacy of early postoperative irradiation with different radiation doses versus the postoperative use of nonsteroidal antiinflammatory drugs (NSAID) for prevention of heterotopic ossification (HO) following prothetic total hip replacement (THP). PATIENTS AND
METHOD: Between 1992 and 1994 585 patients received THP. These patients were randomed in two longitudinal studies each with 3 treatment arms comparing postoperative irradiation with 4 x 3 Gy (101 patients), 1 x 5 Gy (93 patients), 1 x 7 Gy (95 patients) and the postoperative use of the NSAID indometacin for 7 days (113 patients) respectively for 14 days (90 patients) und acetyl salicyl acid (ASS) for 14 days (93 patients). Heterotopic ossification was scored according to the Brooker grading system. One hundred patients receiving no prophylactic therapy after total hip arthroplasty between 1988 and 1992 were analysed and defined as historical control group.
RESULTS: Incidence of heterotopic ossification was 5% in the 4 x 3 Gy group (Brooker grade I 5%, grade II 0%, grade III 0%), 30.5% in the 1 x 5 Gy group (Brooker grade I 24.7%, grade II 4.1%, grade III 1.0%) and 10.5% in the 1 x 7 Gy group (Brooker grade I 10.5%, grade II 0%, grade III 0%). 15.9% of the indometacin-7 days-group developed heterotopic ossification (Brooker grade I 8%, grade II 6.2%, grade III 1.7%, grade IV 0%), 12.2% of the indometacin-14 days-group (Brooker grade I 8.9%, grade II 2.2%, grade III 1.1%) and 37.5% of the ASS-group (Brooker grade I 27.9%, grade II 4.3%, grade III 5.3%). The lowest incidence of heterotopic ossification was found for the 4 xx 3 Gy and the 1 x 7 Gy group, but no significant difference between these two different treatments was observed.
CONCLUSION: Prophylactic irradiation of the operative site after hip replacement is more effective than the use of NSAID. Because no significant difference between the fractionated ingle dose irradiation was found and the latter is more comfortable for patients and more economical, irradiation with single 7 Gy fraction should be preferred.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9454352     DOI: 10.1007/bf03038450

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  29 in total

1.  Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.

Authors:  V D Pellegrini; A A Konski; J A Gastel; P Rubin; C M Evarts
Journal:  J Bone Joint Surg Am       Date:  1992-02       Impact factor: 5.284

2.  [The prevention of ectopic ossification in total hip endoprostheses. Studies on field volume, total dosage and timing of postoperative radiotherapy].

Authors:  H B Gehl; J H Karstens; H R Casser; E Savvidis; J Ammon
Journal:  Rontgenpraxis       Date:  1991-04

3.  Prevention of heterotopic bone formation with early post operative irradiation in high risk patients undergoing total hip arthroplasty: comparison of 10.00 Gy vs 20.00 Gy schedules.

Authors:  P Anthony; H Keys; C M Evarts; P Rubin; C Lush
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-03       Impact factor: 7.038

4.  [Para-articular (ectopic or heterotopic) ossification following total hip prosthesis].

Authors:  S Rudicel
Journal:  Orthopade       Date:  1985-02       Impact factor: 1.087

5.  Para-articular ossification in total hip replacement: an indication for irradiation therapy.

Authors:  R Brunner; E Morscher; R Hünig
Journal:  Arch Orthop Trauma Surg       Date:  1987

6.  Radiotherapy in the prevention of recurrence of paraarticular ossification in total hip prostheses.

Authors:  G J van der Werf; N G van Hasselt; A J Tonino
Journal:  Arch Orthop Trauma Surg       Date:  1985

7.  Ectopic ossification following total hip replacement. Incidence and a method of classification.

Authors:  A F Brooker; J W Bowerman; R A Robinson; L H Riley
Journal:  J Bone Joint Surg Am       Date:  1973-12       Impact factor: 5.284

8.  Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high risk group of patients.

Authors:  I MacLennan; H M Keys; C M Evarts; P Rubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-01       Impact factor: 7.038

9.  Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients.

Authors:  M H Seegenschmiedt; P Martus; A R Goldmann; R Wölfel; L Keilholz; R Sauer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-08-30       Impact factor: 7.038

10.  The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip.

Authors:  M B Coventry; P W Scanlon
Journal:  J Bone Joint Surg Am       Date:  1981-02       Impact factor: 5.284

View more
  3 in total

1.  [Radiation therapy to prevent heterotopic ossification: example of a clinical trial].

Authors:  M H Seegenschmiedt
Journal:  Strahlenther Onkol       Date:  1997-12       Impact factor: 3.621

2.  Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.

Authors:  Emilios E Pakos; Kosmas S Stafilas; Pericles G Tsekeris; Aggelos N Politis; Gregory Mitsionis; Theodore A Xenakis
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

Review 3.  Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelines.

Authors:  M H Seegenschmiedt; O Micke; R Muecke
Journal:  Br J Radiol       Date:  2015-05-08       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.